Skip to content

PFMS - Today’s 8-K Filing Reignites Demand For The Stock

It was early Wednesday afternoon. INOL was up 25,000% or something like that, DMGM was finally falling after a steroid like rally, and PFMS was sitting rather quietly, as it usually does.... until an 8-K filing came through on the wires. This stock had not released news or had a filing all year until today. While some might not find it especially news worthy, as the main headline is a change of CEO's, I find it to be a pivotal event for both the company and its shareholders. Why... you ask?

I think today's 8-K revealed what everyone wanted to know about the company at its future. I have highlighted what I feel is the more pertinent parts of today's filing:

As of the date of this Current Report, the Company continues to be a diversified healthcare staffing and services company. Management believes that the fundamental strategies driving the Company’s business into the future are: (i) organic growth of its current medical services and practices; and (ii) the potential acquisition of small, privately-held home healthcare or physical therapy companies. The Company’s primary operations consist of sales and marketing of medical billing and data service contracts on an outsourced basis. Management further believes that consolidation of the healthcare services industry is at an all-time high as small companies find it difficult to grow due to capital shortages and operational limitations.

Essentially PFMS is pursuing the acquisition of a privately held company, one that will likely bring value to shareholders. This also means the value of the shares should increase. This increase is dependent upon the size and scope of the company. Is it profitable, what type of revenues does it produce? Either way this is adding value and investors today cheered the news.

I don't think this is a one day wonder either. The filing came out later in the session. I would think it is still being digested, meaning the stock should see a nice bump when it opens for trade tomorrow.

If PFMS is not on your watchlist now is the time to add it.

HTLJ - Insiders Purchase 2,096,364 Shares Of Stock




For months I have brought HTLJ to my readers. For months the stock has sat is a fairly narrow range and has found very few buyers. Unfortunately since I first mentioned this stock July 2nd it has barely nudged and even hit a brief low of $.11. I knew with this stock patience was going to be key and at some point this stock will take off, heading up to where it belongs. SEC filings released yesterday showed the CEO and chairman of the board, as well as two directors purchasing over 2 million of company stock. With only 23.3 million shares outstanding that represents close to 10% of all the outstanding shares. If there was something to get investors eyes on this stock this was it.

When insiders of an OTCBB company buy almost a half million dollars of their own stock, that makes an enormous statement to their stock holders and prospective investors. Action speaks louder than words.

This is what I wrote about HTLJ in early July. It is more than relevant today.


In a penny stock market full of stocks that are treated like a burning hot chunk of coal, it is rare to find a stock that is worth holding on to for more than a few hours or a few days. It seems to be even more true today, as investors must be even more careful when making their investment decisions. It is why I am constantly looking for respectable penny stocks, ones that you can invest in and not have to worry about it on a daily basis. One stock that bears looking into is HTLJ - Heartland. This $.20 stock is one of the most undervalued stocks out there, and I believe down the road it could be trading better than $2 a share.


When the CEO, CFO, and company officers are buying back stock you usually can feel confident that the stock is undervalued. Who knows what's going on with a company better than insiders? Recent Form 4 SEC filings have shown Heartlands CEO, CFO, and officers have purchased shares at $.30 which is above today's close and says a lot about where they think the stock is headed. I agree with them and think this stock's days trading under $1 a share are numbered.

Let's delve into some of the company numbers which are very impressive.

The outstanding shares for HTLJ are 22,369,000 and market cap for HTLJ is $5,806,783. The company has $26 million in total assets or over $1 a share in assets and $20 million in liabilities. The company had over $91 million in revenue last year, up from $39 million the year before. How's that for revenue growth?


The company is producing over $4 a share in revenue and its assets outnumber its liabilities by over $6 million. The growth of this company is astounding and the best part is this growth is not based upon over leverage. The company has not burdened itself with debt to grow organcally, and will continue to grow in the future.


I took this right from Heartlands 2009 annual report: "It is our belief that our stock is currently undervalued and that we are better suited to fund current projects through cash provided from operations and financing rather than attempting to sell what we belief to be an undervalued asset and further dilute the securities."


The above statement means you can rule out dilution as a means of growth as well. The company has over a million in cash on hand at the end of the most recent quarter. The also have available credit and other means to grow besides share issuance, which brings me to the only negative, and the reason why this stock isn't already trading over $1. A former board member and shareholder has been liquidating his holdings and still has a substantial position in the stock. Once this disgruntled former employee is out of the way this stock will head right were it belongs.


It will take some time for this stock to finally get its wings, but the reward will be worth it when this stock goes back over $1 and possibly to $4.00. Yahoo has the enterprise value of HTLJ at $21.75 which is almost $1 a share. That would be the theoretical value of the stock if someone wanted to buy them out. I think it is higher than that now as the growth for HTLJ is off the charts.


For those of you who are patient with stocks and don't mind waiting for your gains HTLJ is your stock. It is a solid company and currently trading over 75% less than it's fair value. At some point soon that will change and the Guru is giving you advanced notice.

Top Stocks are RMDM, QASP, INOL

Top stocks talked about: RMDM, QASP, INOL, DGMA, ITCJ, EFIR, MNDP, AAVG, KSQR, CLDR, DMGM, LQMT RMD Entertainment Group (RMDM) has traded 15.9 m shares today. RMDM‘s last trade price was $0.000 + $ 0.000 (0.00%) after opening today at $0.0001 . RMDM hit an intraday high today of $0.000 and a low of $0.000. What [...]

INOL - Up 3,500%+ on the session


If there was any further evidence needed that the money is returning to the penny stocks, look no further than the latest "turn my Ben Franklin into $3,000 in less than an hour" stock INOL.

Pre-market news (pasted below) is the culprit for this enormous rally. As I stated the other day with DMGM, and for much of the same reasons, this is likely not a one day rally.



InoLife Technologies, Inc. to Market a Plavix Metabolizing Test to the Medical Industry
DNA Test Enables Physicians to Predict Medication Response in Patients for Effective Treatment
RALEIGH, NC, Sep 01, 2010 (eTeligis.com via COMTEX) InoLife Technologies, Inc. (OTCBB: INOL), a service based healthcare products development, integration and marketing Company, announced today it will provide and market a proprietary metabolizing test to physicians and practitioners to identify how a patient's genetic makeup may affect the body's response to Plavix (colpidogrel).The test will only be made available to physicians.

The Food and Drug Administration recently announced that Plavix must now carry a so-called "black box" warning label after a landmark study revealed that patients who were "non-responders" as a result of a genetic variation were "3.58 times more likely to have a fatal stroke or myocardial infarction."

Plavix, an $8-billion-a-year drug and considered to be the second best selling drug in the world, reduces the risk of heart attack, stroke, and cardiovascular death in patients with cardiovascular disease by making platelets less likely to form blood clots.Plavix does not have its anti-platelet effects until it is metabolized into its active form by the liver enzyme, CYP2C19.

"We determined that there are three critical problems that can lead to a level of non-response to Plavix," said Dr. Frederic J. Vagnini, M.D., FACS, a board certified cardiovascular surgeon who, after more than 20 years of performing heart surgery, has turned his clinical practice to the prevention of heart and related diseases. "First, in anyone an abnormality may be present within a gene abbreviated as CYP2C19 (and other variants) which significantly increases the risk of stroke or death due to clotting failure. Second, there are different variants or mutations between ethnic groups; some studies have indicated that one in three Caucasians and 40% of Asian of African-American populations have this abnormality.

"Among clinicians there have been discussions centering on differing dosing approaches. Perhaps the most important result of InoLife's DNA test is that each patient will be able to have an individually tailored course of treatment since some require longer periods on it," Vagnini stated.

InoLife Technologies feels that this is an important test for those who take Plavix or who may need to take Plavix in the future. The Company is very pleased that by addressing the black box warning, those who can be helped by this medication will be.

InoLife's Plavix Metabolizing Test is only available to physicians and medical professionals. It is not available for home use. Please ask your physician.

(Plavix is a trademark of Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership.)

About InoLife Technologies, IncPositioned for growth and success in a burgeoning market, InoLife Technologies,www.inolifetech.com, is primarily focused on products, services and solutions that will enable state-of-the-art healthcare for today and the future for a diverse base of customers and end-users. The Company's mission is to identify, develop, integrate and bring to market innovative healthcare-based products and services that provide timely and practical solutions for both humans and companion animals.The primary products and services that InoLife is currently addressing focuses upon those specific products and services that provide key solutions through the innovative use of specific DNA testing and Genetic analysis systems.

The principal customers of InoLife's products and services are healthcare providers, physicians, practitioners, hospitals, outpatient facilities and veterinarians. Emphasis is being placed on individuals with a direct need for the DNA testing solutions. InoLife will be marketing and distributing its proprietary products to a wide variety of customers through e-commerce, direct sales, healthcare providers, distributors and retail sellers including pharmacies, specialty retailers and drugstores.

Forward-Looking StatementsSafe Harbor Statement under the Private securities Litigation Reform Act of 1995: The statements contained herein, which are not historical, are forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in the forward-looking statements including, but not limited to, certain delays beyond the Company's control with respect to market acceptance of new technologies, products and services, delays in testing and evaluation of products and services, and other risks detailed from time to time in the Company's filings with the Securities and Exchange Commission.

Contact:Henry HarrisonIR Pro, 2.0, Inc.407-862-5151hharrison@insidewallstreet.comwww.irprpro.com

Copyright (C) 2009 eTeligis.com, All Rights Reserved
-0-

INDUSTRY KEYWORD: ADVISORY

Wednesday’s Stocks To Watch - UWRL, BFHJ, HTLJ, XYNH

UWRL the buying is finally starting to show through in the price per share. I would not be surprised to see UWRL break $.002 again as the week progresses. From there we are only 300% away from where I think UWRL will trade soon.

BFHJ the online casino appears to be getting closer to completion. This news is not priced into this stock and I think when it hits the wires BFHJ will be pushing toward $.005 and then $.01.

HTLJ some rather large and significant insider transaction hit the wires on Tuesday. Over 2 million shares have entered the hands of insiders. This represents almost 10% of the outstanding shares. I have said it before and I will say it again, I think HTLJ will be trading over $1 in the near future and is fairly valued at $2 - $3 right now, and possibly more down the road as the growth continues.

XYNH the financials are to be out any day now per the last press release. This should help bolster shares of the stock. The re-awakening of this stock is still in its infancy stages.

Top Stocks are HSCC, RPPR, DGMA

Top stocks talked about: HSCC, RPPR, DGMA, ITCJ, MNDP, DMGM, ATNP, ICOA, HFBG, SKGP, BMGP Homeland Security Corp. (HSCC) has traded 139.8 k shares today. HSCC‘s last trade price was $0.040 -0.005 (-6.98%) after opening today at $0.045 . HSCC hit an intraday high today of $0.045 and a low of $0.030. What our members are [...]

Tuesday Stocks To Watch - UWRL, BFHJ, SSWC, PRGJ


UWRL the volume is picking up, and the price has stabilized. The stock is poised to mount a nice rally from here and start its move toward my $.006 target.

BFHJ the buying interest waned into the afternoon and the bid suffered. I think this opens up a great opportunity for those looking to get into this stock. Patience can be a virtue and I think anyone getting in at these levels will be happy down the road. One day does not make or break the upward trend. There will be dips and rips with any stock. If you believe in the company, its management, business model, and share structure, than one step back will not affect the ultimate goal.

SSWC at $.0005 is great position to play the next move higher for the stock. With so much going good for this company, the stock has no choice but to reflect that. i think it sees $.001 - $.0015 with a week or two, making today's selling a great buying opportunity.

PRGJ the bid is starting to firm and volume is coming into this stock now. It is only a matter of time before the market better reflects the value of these shares. I think fair value is $.04 - $.05. At a Monday closing price of $.012 this amounts to a roughly 400% gain from here.

LBSR - Chart of The Day…. Again





LBSR up another ~20% today. Those $.0012 shares from a few months ago are looking very nice at $.14.

If you had purchased $1,200 worth of stock at that low those same shares today are worth $140,000.

That is what trading penny stocks is all about. Turning $1,200 into $140,000 in two months.


With your ideas we can build a better Alert HQ together

I am planning to add a premium section to the Trade-Radar web site. This members-only area will consist of content similar to Alert HQ but more unique. In fact, I will be naming it Alert HQ Premium and there will be a modest recurring charge to access the data.

Tell me what you'd like to see --

I would like to ask readers to submit ideas for content. Tell me what kinds of custom stock screens you would like to see and I'll try to build them.

Just to get the ball rolling, let me describe what I have built so far. The following alert lists will be generated three times per week based on our scans of the NYSE, NASDAQ and AMEX:
  • Value stocks breaking out
  • Reasonable Value Momentum Stocks to Buy on a pullback
  • Dividend Growth at Reasonable Value
  • Over-priced and Over-bought Report
  • Ebb and Flow Report - stocks on the move based on weekly data
  • Top 50 stocks based on Total Return Ratio
I think these alert lists will be unique in that I will be combining value analysis and technical analysis in order to bring you low-risk investment candidates.

I am thinking of providing some alert lists dedicated solely to ETFs. Any suggestions? Would you be interested in best and worst performing ETFs over the last week? Perhaps a report dedicated to the ProShares family of ETFs?

I'd very much like to hear your ideas --

Where do current stock screeners fall short? How can I help get you the information you need?

Please leave a comment or send me an email.

Why not share or Tweet this post so others can contribute their ideas? The more suggestions we have the better we can make Alert HQ Premium.

Let's do this together!


Top Stocks are HSCC, DMGM, IFRS

Top stocks talked about: HSCC, DMGM, IFRS, DGMA, SKGP, DTRO, DKGR, GFGUE, UWRL, EFIR, EMOT Homeland Security Corp. (HSCC) has traded 557.19 k shares today. HSCC‘s last trade price was $0.042 + $ 0.002 (5.00%) after opening today at $0.04 . HSCC hit an intraday high today of $0.049 and a low of $0.028. Some moderate [...]